Fig. 2From: Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failureFreedom of oxygenator-change at 15 days between high-dose and low-dose heparinization groups. Data is censored for decannulation or mortality. HR hazard ratio, CI confidence interval. aAdjusted for age, gender, body-mass-index, Respiratory ECMO Survival Prediction (RESP) score, Simplified acute physiology score II, sequential organ failure assessment renal sub-score, ECMO runtime, sepsis, coronary artery disease, prior aspirin use, mean ECMO blood flow, baseline fibrinogen, d-dimer and antithrombin III levels.Back to article page